Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)
暂无分享,去创建一个
Pauline M. Rudd | Inge Nelissen | Raymond A. Dwek | R. Dwek | P. E. Van den Steen | G. Opdenakker | B. Dubois | I. Nelissen | P. Rudd | Ghislain Opdenakker | Bénédicte Dubois | Philippe E. Van den Steen
[1] T. Putti,et al. The Ras/Mitogen-Activated Protein Kinase Pathway Inhibitor and Likely Tumor Suppressor Proteins, Sprouty 1 and Sprouty 2 Are Deregulated in Breast Cancer , 2004, Cancer Research.
[2] S. Saad,et al. Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts , 2000, Breast Cancer Research and Treatment.
[3] R. Suzuki,et al. Experimental metastasis is suppressed in MMP-9-deficient mice , 1999, Clinical & Experimental Metastasis.
[4] Gurmit Singh,et al. Transforming growth factor β1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells , 1999, Clinical and Experimental Metastasis.
[5] R. Muschel,et al. Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat , 1998, Clinical & Experimental Metastasis.
[6] Y. Okada,et al. Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and β2-microglobulin amyloidosis , 1996, Virchows Archiv.
[7] R. Reich,et al. Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells , 1995, Clinical & Experimental Metastasis.
[8] T. Miyatake,et al. Suppressive effect of camostat mesilate (FOY 305) on acute experimental allergic encephalomyelitis (EAE) , 1988, Neurochemical Research.
[9] F. Kikkawa,et al. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells , 2004, Clinical & Experimental Metastasis.
[10] W. Yung,et al. Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades , 2004, Clinical & Experimental Metastasis.
[11] L. Liotta,et al. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas , 2004, Clinical & Experimental Metastasis.
[12] 方福德. 构成性表达(constitutive expression) , 2003 .
[13] R. Rey. Regulation of spermatogenesis. , 2003, Endocrine development.
[14] A. Goris,et al. Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis , 2002, Journal of the Neurological Sciences.
[15] G. Opdenakker,et al. Gelatinase B deficiency protects against endotoxin shock , 2002, European journal of immunology.
[16] C. Janson,et al. Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase. , 2002, Acta crystallographica. Section D, Biological crystallography.
[17] W. Bao,et al. Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. , 2002, Cardiovascular research.
[18] S. Rafii,et al. Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.
[19] A. Henney,et al. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor. , 2002, Journal of molecular biology.
[20] D. Devine,et al. Mannose-binding Lectin (MBL) Mutants Are Susceptible to Matrix Metalloproteinase Proteolysis , 2002, The Journal of Biological Chemistry.
[21] B. Marmer,et al. Substrate Binding of Gelatinase B Induces Its Enzymatic Activity in the Presence of Intact Propeptide* , 2002, The Journal of Biological Chemistry.
[22] R. Romero,et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. , 2002, Molecular human reproduction.
[23] Pauline M Rudd,et al. An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. , 2002, Analytical biochemistry.
[24] F. Luscinskas,et al. Neutrophils from MMP‐9‐ or neutrophil elastase‐deficient mice show no defect in transendothelial migration under flow in vitro , 2002, Journal of leukocyte biology.
[25] G. Schuler,et al. Matrix Metalloproteinases 9 and 2 Are Necessary for the Migration of Langerhans Cells and Dermal Dendritic Cells from Human and Murine Skin1 , 2002, The Journal of Immunology.
[26] A. Mantovani,et al. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] E. Tsilibary,et al. Effects of collagen IV on neuroblastoma cell matrix-related functions. , 2002, Experimental cell research.
[28] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[29] W. Fan,et al. Increased MMP-2 Expression in Connective Tissue Growth Factor Over-expression Vascular Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.
[30] Yong Jiang,et al. Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells. , 2002, Cancer research.
[31] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[32] P. E. Van den Steen,et al. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post‐translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] Takashi Sato,et al. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma , 2002, Cancer research.
[34] G. Rice,et al. Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade , 2002 .
[35] R. Mecham,et al. Processing of Type II Procollagen Amino Propeptide by Matrix Metalloproteinases* , 2002, The Journal of Biological Chemistry.
[36] T. Ikebe,et al. The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-kappaB-mediated protease production by oral cancer. , 2002, Biochimica et biophysica acta.
[37] G. Opdenakker,et al. Regulation of gelatinase B in human monocytic and endothelial cells by PECAM‐1 ligation and its modulation by interferon‐beta , 2002, Journal of leukocyte biology.
[38] R L Juliano,et al. Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. , 2002, Annual review of pharmacology and toxicology.
[39] G. Rice,et al. Association between αvβ6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen‐dependent matrix degradation in ovarian cancer , 2002 .
[40] G. Rice,et al. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer. , 2002, Journal of cellular biochemistry.
[41] G. Rice,et al. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. , 2002, Carcinogenesis.
[42] T. Keck,et al. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. , 2002, Gastroenterology.
[43] S. Silbiger,et al. Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. , 2002, American journal of physiology. Renal physiology.
[44] C. Overall,et al. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. , 2002, Cancer research.
[45] P. Plinkert,et al. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. , 2001, Experimental cell research.
[46] Jun Yao,et al. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells , 2001, Oncogene.
[47] S. Rennard,et al. Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degradation. , 2001, The Journal of allergy and clinical immunology.
[48] R. V. Sharma,et al. Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. , 2001, American journal of physiology. Heart and circulatory physiology.
[49] C. Overall,et al. Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.
[50] M. Mosunjac,et al. Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases. , 2001, AIDS research and human retroviruses.
[51] A. Burgess,et al. Regulation of Transforming Growth Factor-β Signaling , 2001 .
[52] E. Benveniste,et al. Transcriptional Suppression of Matrix Metalloproteinase-9 Gene Expression by IFN-γ and IFN-β: Critical Role of STAT-1α1 , 2001, The Journal of Immunology.
[53] M. Morgan,et al. Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines , 2001, Molecular carcinogenesis.
[54] S. Itohara,et al. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy , 2001, Nature Medicine.
[55] C. Munaut,et al. Distinct pathways in the over-expression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension. , 2001, Matrix biology : journal of the International Society for Matrix Biology.
[56] S. Grässel,et al. Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9). , 2001, Journal of cell science.
[57] M. Sittinger,et al. Secretion of Gelatinases and Activation of Gelatinase A (MMP-2) by Human Rheumatoid Synovial Fibroblasts , 2001, Biological chemistry.
[58] R. Dwek,et al. Matrix remodelling enzymes, the protease cascade and glycosylation. , 2001, Biochimica et biophysica acta.
[59] K. Isshiki,et al. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. , 2001, Kidney international.
[60] P. E. Van den Steen,et al. Gelatinase B: a tuner and amplifier of immune functions. , 2001, Trends in immunology.
[61] R. Hershkoviz,et al. Human Mast Cells Release Metalloproteinase-9 on Contact with Activated T Cells: Juxtacrine Regulation by TNF-α1 , 2001, The Journal of Immunology.
[62] C. Wolf‐Peeters,et al. Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle. , 2001, The American journal of pathology.
[63] S. Davidge,et al. Matrix metalloproteinases regulate neutrophil‐endothelial cell adhesion through generation of endothelin‐1[1–32] , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[64] J. Sleeman,et al. CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. , 2001, Journal of cell science.
[65] D. Schlaepfer,et al. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. , 2001, Cancer research.
[66] M. Fini,et al. Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia , 2001, The Journal of Neuroscience.
[67] M Stürzl,et al. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. , 2001, Molecular biology of the cell.
[68] S. Itohara,et al. Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia , 2001, Neuroreport.
[69] A. Weyrich,et al. Differential Regulation of Matrix Metalloproteinase-9 by Monocytes Adherent to Collagen and Platelets , 2001, Circulation research.
[70] Y. Jiang,et al. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. , 2001, Biochemical and biophysical research communications.
[71] S. Ye,et al. Polymorphisms in Matrix Metalloproteinase-1, -3, -9, and -12 Genes in Relation to Subarachnoid Hemorrhage , 2001, Stroke.
[72] M. Karin,et al. Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.
[73] R. V. Sharma,et al. Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells. , 2001, Journal of applied physiology.
[74] T. Lehtimäki,et al. Coronary Artery Complicated Lesion Area Is Related to Functional Polymorphism of Matrix Metalloproteinase 9 Gene: An Autopsy Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[75] G. Bancroft,et al. Production of Matrix Metalloproteinases in Response to Mycobacterial Infection , 2001, Infection and Immunity.
[76] H. Duan,et al. v-Ha-RaS oncogene upregulates the 92-kDa type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-kappaB. , 2001, Free radical biology & medicine.
[77] R. Fridman,et al. Differential regulation of matrix metalloproteinase‐9, tissue inhibitor of metalloproteinase‐1 (TIMP‐1) and TIMP‐2 expression in co‐cultures of prostate cancer and stromal cells , 2001, International journal of cancer.
[78] D. Missé,et al. HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway. , 2001, Blood.
[79] D. Argyle,et al. Molecular cloning and characterization of canine metalloproteinase-9 gene promoter. , 2001, Gene.
[80] M. Stack,et al. Functional Interplay between Type I Collagen and Cell Surface Matrix Metalloproteinase Activity* , 2001, The Journal of Biological Chemistry.
[81] R. Kiss,et al. Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[82] Takashi Kobayashi,et al. A novel mechanism of matrix metalloproteinase‐9 gene expression implies a role for keratinization , 2001, EMBO reports.
[83] H. Matsuda,et al. Mast cell MMP-9 production enhanced by bacterial lipopolysaccharide. , 2001, The Journal of veterinary medical science.
[84] M. Padrines,et al. Potential synergies between matrix proteins and soluble factors on resorption and proteinase activities of rabbit bone cells. , 2001, Histology and histopathology.
[85] L. Zhuang,et al. Effects of Matrix Proteins on the Expression of Matrix Metalloproteinase-2, -9, and -14 and Tissue Inhibitors of Metalloproteinases in Human Cytotrophoblast Cells During the First Trimester1 , 2001, Biology of reproduction.
[86] V. Wee Yong,et al. Metalloproteinases in biology and pathology of the nervous system , 2001, Nature Reviews Neuroscience.
[87] Y. Suh,et al. Effects of the β-Amyloid and Carboxyl-terminal Fragment of Alzheimer's Amyloid Precursor Protein on the Production of the Tumor Necrosis Factor-α and Matrix Metalloproteinase-9 by Human Monocytic THP-1* , 2001, The Journal of Biological Chemistry.
[88] P. Tsao,et al. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. , 2001, Circulation research.
[89] J W Smith,et al. Substrate Hydrolysis by Matrix Metalloproteinase-9* , 2001, The Journal of Biological Chemistry.
[90] A. Newby,et al. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. , 2001, Cardiovascular research.
[91] Inge Nelissen,et al. Gelatinase B functions as regulator and effector in leukocyte biology , 2001, Journal of leukocyte biology.
[92] P. Speight,et al. αvβ6integrin promotes invasion of squamous carcinoma cells through up‐regulation of matrix metalloproteinase‐9 , 2001 .
[93] P. Speight,et al. αvβ6 Integrin Upregulates Matrix Metalloproteinase 9 and Promotes Migration of Normal Oral Keratinocytes , 2001 .
[94] M. Díaz-Guerra,et al. Expression of cyclooxygenase‐2 promotes the release of matrix metalloproteinase‐2 and ‐9 in fetal rat hepatocytes , 2001, Hepatology.
[95] J. Tonn,et al. Production of MMPs in Human Cerebral Endothelial Cells and Their Role in Shedding Adhesion Molecules , 2001, Journal of neuropathology and experimental neurology.
[96] D. Collen,et al. Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activity. , 2001, Thrombosis research.
[97] H. Tschesche,et al. The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. , 2001, European journal of biochemistry.
[98] G. Giannelli,et al. Human Hepatocellular Carcinoma (HCC) Cells Require Both α3β1 Integrin and Matrix Metalloproteinases Activity for Migration and Invasion , 2001, Laboratory Investigation.
[99] A. Sala,et al. Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia , 2001, The Journal of Neuroscience.
[100] D. Greaves,et al. Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 Gene , 2001, The Journal of Biological Chemistry.
[101] M. Stack,et al. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. , 2001, Cancer research.
[102] J. Sun,et al. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. , 2001, Cancer research.
[103] J. Michel,et al. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. , 2001, Cardiovascular Research.
[104] M. Karin,et al. Mammalian MAP kinase signalling cascades , 2001, Nature.
[105] D. Crowe,et al. Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway. , 2001, International journal of oncology.
[106] G. Striker,et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. , 2001, Journal of the American Society of Nephrology : JASN.
[107] D. Ribatti,et al. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma. , 2001, Life sciences.
[108] A. Komiyama,et al. Prostacyclin Inhibits the Production of MMP-9 Induced by Phorbol Ester through Protein Kinase A Activation, but Does Not Affect the Production of MMP-2 in Human Cultured Mesangial Cells , 2001, Kidney and Blood Pressure Research.
[109] J. Heino,et al. Three-dimensional collagen regulates collagen gene expression by a mechanism that requires serine/threonine kinases and is independent of mechanical contraction. , 2001, Biochemical and biophysical research communications.
[110] Gyeong-Moon Kim,et al. Glucocorticoid Receptor-Mediated Suppression of Activator Protein-1 Activation and Matrix Metalloproteinase Expression after Spinal Cord Injury , 2001, The Journal of Neuroscience.
[111] W. Garner,et al. Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin. , 2001, The Journal of biological chemistry.
[112] A. Burgess,et al. Regulation of transforming growth factor-beta signaling. , 2001, Molecular cell biology research communications : MCBRC.
[113] 神原 千晶. Vascular cell adhesion molecule-1-mediated matrix metalloproteinase-2 induction in peripheral blood T cells is up-regulated in patients with HTLV-1-associated myelopathy , 2001 .
[114] E. Benveniste,et al. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. , 2001, Journal of immunology.
[115] S. Weiss,et al. Role of stromelysin 1 and gelatinase B in experimental acute lung injury. , 2001, American journal of respiratory cell and molecular biology.
[116] P. Speight,et al. alpha v beta 6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. , 2001, The Journal of investigative dermatology.
[117] Y. Nishimura,et al. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[118] D. Crowe,et al. Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression. , 2001, Neoplasia.
[119] D. Boyd,et al. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation. , 2001, The Journal of biological chemistry.
[120] N. Ahmed,et al. The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression. , 2001, International journal of cancer.
[121] G. Giannelli,et al. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion. , 2001, Laboratory investigation; a journal of technical methods and pathology.
[122] P. Speight,et al. AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. , 2001, International journal of cancer.
[123] D. Ribatti,et al. alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. , 2001, Experimental hematology.
[124] W. Colucci,et al. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. , 2001, American journal of physiology. Cell physiology.
[125] B. Sheu,et al. A novel role of metalloproteinase in cancer-mediated immunosuppression. , 2001, Cancer research.
[126] R. Dwek,et al. O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme. , 2000, Biochemistry.
[127] H. Haller,et al. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. , 2000, Journal of cell science.
[128] Raymond Sawaya,et al. Effects of radiation on the levels of MMP‐2, MMP‐9 and TIMP‐1 during morphogenic glial‐endothelial cell interactions , 2000, International journal of cancer.
[129] J. Spencer,et al. Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype. , 2000, The American journal of pathology.
[130] A. Cho,et al. Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[131] J. Pfeilschifter,et al. Amplification of IL-1β-Induced Matrix Metalloproteinase-9 Expression by Superoxide in Rat Glomerular Mesangial Cells Is Mediated by Increased Activities of NF-κB and Activating Protein-1 and Involves Activation of the Mitogen-Activated Protein Kinase Pathways1 , 2000, The Journal of Immunology.
[132] Donald E. Ingber,et al. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. , 2000, Journal of cell science.
[133] Thiennu H. Vu,et al. Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones , 2000, The Journal of cell biology.
[134] P. E. Van den Steen,et al. Structural Characterization of the Catalytic Active Site in the Latent and Active Natural Gelatinase B from Human Neutrophils* , 2000, The Journal of Biological Chemistry.
[135] S. Chien,et al. Biomechanical regulation of matrix metalloproteinase‐9 in cultured chondrocytes , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[136] M. Ratajczak,et al. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. , 2000, Experimental hematology.
[137] M. Jaurand,et al. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases , 2000, British Journal of Cancer.
[138] D. Hanahan,et al. MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.
[139] P. E. Van den Steen,et al. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. , 2000, Blood.
[140] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[141] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[142] L. Sjulson,et al. Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration , 2000, Journal of Neuroimmunology.
[143] M. Fini,et al. Effects of Matrix Metalloproteinase-9 Gene Knock-Out on Morphological and Motor Outcomes after Traumatic Brain Injury , 2000, The Journal of Neuroscience.
[144] S. Shapiro,et al. Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. , 2000, The Journal of biological chemistry.
[145] Y. Masuho,et al. Membrane‐type 6 matrix metalloproteinase (MT6‐MMP, MMP‐25) is the second glycosyl‐phosphatidyl inositol (GPI)‐anchored MMP , 2000, FEBS letters.
[146] F. Higashino,et al. Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade. , 2000, Cancer letters.
[147] G. Opdenakker,et al. Gelatinase B deficiency impairs reproduction. , 2000, The Journal of clinical investigation.
[148] C. López-Otín,et al. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. , 2000, Cancer research.
[149] Z. Werb,et al. The Serpin α1-Proteinase Inhibitor Is a Critical Substrate for Gelatinase B/MMP-9 In Vivo , 2000, Cell.
[150] R. Hynes,et al. Mouse keratinocytes immortalized with large T antigen acquire alpha3beta1 integrin-dependent secretion of MMP-9/gelatinase B. , 2000, Journal of cell science.
[151] D. Noonan,et al. The α3β1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (mmp‐9) activity , 2000 .
[152] T. Betsuyaku,et al. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. , 2000, The American journal of pathology.
[153] V. Yong,et al. Interleukin‐1 is a key regulator of matrix metalloproteinase‐9 expression in human neurons in culture and following mouse brain trauma in vivo , 2000, Journal of neuroscience research.
[154] G. Opdenakker,et al. In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[155] T. Betsuyaku,et al. Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. , 2000, The American journal of pathology.
[156] J. Keiser,et al. Hepatocyte growth factor enhances MMP activity in human endothelial cells. , 2000, Biochemical and biophysical research communications.
[157] T. Olsson,et al. Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis , 2000, Journal of Neuroimmunology.
[158] M. Horton,et al. Smooth muscle cell matrix metalloproteinase production is stimulated via alpha(v)beta(3) integrin. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[159] R. Rezzonico,et al. Th2 Cell Membrane Factors in Association with IL-4 Enhance Matrix Metalloproteinase-1 (MMP-1) While Decreasing MMP-9 Production by Granulocyte-Macrophage Colony-Stimulating Factor-Differentiated Human Monocytes1 , 2000, The Journal of Immunology.
[160] S. Shapiro,et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.
[161] G. Stark,et al. Complex roles of Stat1 in regulating gene expression , 2000, Oncogene.
[162] A. Ricca,et al. bcl‐2 over‐expression enhances NF‐κB activity and induces mmp‐9 transcription in human MCF7ADR breast‐cancer cells , 2000, International journal of cancer.
[163] Bao Q. Pham,et al. Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B* , 2000, The Journal of Biological Chemistry.
[164] G. Koh,et al. Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway. , 2000, Biochemical and biophysical research communications.
[165] J. Lissitzky,et al. Anti‐β4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP‐2 expression , 2000, International journal of cancer.
[166] Stuart A. Aaronson,et al. Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.
[167] C. Lafuma,et al. Induction of Matrix Metalloproteinase MMP‐9 (92‐kDa Gelatinase) by Retinoic Acid in Human Neuroblastoma SKNBE Cells , 2000, Journal of neurochemistry.
[168] G. Hou,et al. Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. , 2000, The American journal of pathology.
[169] G. Fiucci,et al. Phospholipase D: molecular and cell biology of a novel gene family. , 2000, The Biochemical journal.
[170] L. Kotra,et al. Characterization of the Monomeric and Dimeric Forms of Latent and Active Matrix Metalloproteinase-9 , 2000, The Journal of Biological Chemistry.
[171] I. Stamenkovic,et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.
[172] C. López-Otín,et al. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. , 2000, Journal of cell science.
[173] K. Okazaki,et al. Constitutive activation of MAP kinase kinase (MEK1) is critical and sufficient for the activation of MMP-2. , 2000, Experimental cell research.
[174] G. Opdenakker,et al. Expression of gelatinase B in trachomatous conjunctivitis , 2000, The British journal of ophthalmology.
[175] J. Pelletier,et al. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[176] D. Noonan,et al. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. , 2000, International journal of cancer.
[177] T. Ugarova,et al. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. , 2000, Experimental cell research.
[178] T. Sato,et al. A citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts. , 2000, The Journal of rheumatology.
[179] K. Harada,et al. Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor kappaBalpha complementary DNA into immortalized human salivary gland acinar cells. Prevention of the destruction of the acinar structu , 2000, Arthritis and rheumatism.
[180] J. Pfeilschifter,et al. Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. , 2000, Kidney international.
[181] D. Ruiter,et al. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo. , 2000, International journal of cancer.
[182] J. Cowland,et al. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules , 1999, Journal of leukocyte biology.
[183] H Yonas,et al. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. , 1999, Stroke.
[184] R. Sciot,et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. , 1999, The Journal of clinical investigation.
[185] M. Matsumoto,et al. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. , 1999, Journal of immunology.
[186] D. Lovett,et al. YB-1 regulation of the human and rat gelatinase A genes via similar enhancer elements. , 1999, Journal of the American Society of Nephrology : JASN.
[187] R. V. Sharma,et al. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[188] Y. Itoh,et al. Membrane Type 4 Matrix Metalloproteinase (MT4-MMP, MMP-17) Is a Glycosylphosphatidylinositol-anchored Proteinase* , 1999, The Journal of Biological Chemistry.
[189] H. Kuivaniemi,et al. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. , 1999, Biochemical and biophysical research communications.
[190] P. Chan,et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[191] A. Henney,et al. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2–13.1 , 1999, Human Genetics.
[192] T. Sharshar,et al. Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndrome , 1999, Neurology.
[193] E. Middleton,et al. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis‐associated properties in A431 cells overexpressing epidermal growth factor receptor , 1999, British journal of pharmacology.
[194] R. Dwek,et al. Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. , 1999, Biochemistry.
[195] J. Yagüe,et al. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. , 1999, Blood.
[196] B. Janji,et al. Autocrine TGF‐β‐regulated expression of adhesion receptors and integrin‐linked kinase in HT‐144 melanoma cells correlates with their metastatic phenotype , 1999, International journal of cancer.
[197] E. Benveniste,et al. The Transcription Factors Sp1, Sp3, and AP-2 Are Required for Constitutive Matrix Metalloproteinase-2 Gene Expression in Astroglioma Cells* , 1999, The Journal of Biological Chemistry.
[198] A. Luttun,et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.
[199] Z. Werb,et al. Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes , 1999, The Journal of Neuroscience.
[200] F. Berditchevski,et al. Function of α3β1–Tetraspanin Protein Complexes in Tumor Cell Invasion. Evidence for the Role of the Complexes in Production of Matrix Metalloproteinase 2 (Mmp-2) , 1999, The Journal of cell biology.
[201] R. Willemze,et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[202] T. Seifert,et al. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis , 1999, Journal of Neuroimmunology.
[203] F Ghezzi,et al. Matrix metalloproteinases-9 in preterm and term human parturition. , 1999, The Journal of maternal-fetal medicine.
[204] K. Conant,et al. Cerebrospinal fluid levels of MMP‐2, 7, and 9 are elevated in association with human immunodeficiency virus dementia , 1999, Annals of neurology.
[205] R. Pereira,et al. Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. , 1999, American journal of physiology. Endocrinology and metabolism.
[206] M. Fujimura,et al. Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier Dysfunction , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[207] P. Grammas,et al. Gelatinase A expression in endothelial cells is regulated by at least two cis-acting promoter elements. , 1999, Biochimica et biophysica acta.
[208] L. Zheng,et al. Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[209] M. Hoshino,et al. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. , 1999, The Journal of allergy and clinical immunology.
[210] Z. Galis,et al. Mechanical stretching of human saphenous vein grafts induces expression and activation of matrix-degrading enzymes associated with vascular tissue injury and repair. , 1999, Experimental and molecular pathology.
[211] Timo Sorsa,et al. Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.
[212] James Varani,et al. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor‐stimulated human epidermal keratinocytes , 1999, Journal of cellular physiology.
[213] M. Hendrix,et al. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. , 1999, Cancer research.
[214] T. Seifert,et al. Differential expression of matrix metalloproteinases in bacterial meningitis. , 1999, Brain : a journal of neurology.
[215] C. Legrand,et al. Airway Epithelial Cell Migration Dynamics , 1999, The Journal of cell biology.
[216] Y. Sasaguri,et al. Shortened microsatellite d(CA)21 sequence down‐regulates promoter activity of matrix metalloproteinase 9 gene , 1999, FEBS letters.
[217] P. Fuhr,et al. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy , 1999, Neurology.
[218] G. Opdenakker,et al. Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins , 1999, Glia.
[219] C. P. Leblond,et al. Active gelatinase B is identified by histozymography in the cartilage resorption sites of developing long bones , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.
[220] C. Flaitz,et al. PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma , 1999, British Journal of Cancer.
[221] Hiroki Sato,et al. Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2 , 1999, Journal of Virology.
[222] B. Dahlén,et al. Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma , 1999, Thorax.
[223] J. Mudgett,et al. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[224] G. Schneider,et al. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. , 1999, Science.
[225] P. Kivisäkk,et al. Metalloproteinases and their tissue inhibitors in multiple sclerosis. , 1999, Journal of autoimmunity.
[226] C. López-Otín,et al. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors. , 1999, Cancer research.
[227] J. Koziol,et al. Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[228] D. Faller,et al. Feline Leukemia Virus Long Terminal Repeat Activates Collagenase IV Gene Expression through AP-1 , 1999, Journal of Virology.
[229] M. d’Ortho,et al. Balance between MMP‐9 and TIMP‐1 Expressed by Human Bronchial Epithelial Cells: Relevance to Asthma , 1999, Annals of the New York Academy of Sciences.
[230] P. Nelson,et al. Chemokine‐Induced Extravasation of MonoMac 6 Cells: Chemotaxis and MMP Activity , 1999, Annals of the New York Academy of Sciences.
[231] Napoleone Ferrara,et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.
[232] M. Selman,et al. Expression and Localization of TIMP‐1, TIMP‐2, MMP‐13, MMP‐2, and MMP‐9 in Early and Advanced Experimental Lung Silicosis , 1999, Annals of the New York Academy of Sciences.
[233] M. Nakajima,et al. Retinoic acid synergizes with cyclic AMP to enhance MMP-2 basal promoter activity. , 1999, Biochemical and biophysical research communications.
[234] J. Rozmus,et al. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. , 1999, Blood.
[235] H. Nishigori,et al. ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy. , 1999, Life sciences.
[236] T. Tuan,et al. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase‐B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[237] P. Carmeliet,et al. Temporal and Topographic Matrix Metalloproteinase Expression after Vascular Injury in Mice , 1999, Thrombosis and Haemostasis.
[238] R. Willemze,et al. Mechanisms underlying hematopoietic stem cell mobilization induced by the CXC chemokine interleukin-8. , 1999, Current opinion in hematology.
[239] A. Zalewski,et al. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[240] J. Weitzman,et al. Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells. , 1999, Journal of Cell Science.
[241] F. Balkwill,et al. MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts , 1999, British Journal of Cancer.
[242] A. Gulino,et al. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[243] G. Butler,et al. Human Tissue Inhibitor of Metalloproteinases 3 Interacts with Both the N- and C-terminal Domains of Gelatinases A and B , 1999, The Journal of Biological Chemistry.
[244] A. Evans,et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. , 1999, Circulation.
[245] D. Fishman,et al. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. , 1999, Cancer research.
[246] C. Figdor,et al. Biology of IL‐8‐Induced Stem Cell Mobilization , 1999, Annals of the New York Academy of Sciences.
[247] I. Thesleff,et al. Timp-1, -2 and -3 show coexpression with gelatinases A and B during mouse tooth morphogenesis. , 1999, European journal of oral sciences.
[248] R. Johnston,et al. © 1999 Cancer Research Campaign Article no. bjoc.1998.0291 , 2022 .
[249] T. Chard,et al. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy. , 1999, Molecular human reproduction.
[250] P. Ruck,et al. Parturition at term: parallel increases in interleukin-8 and proteinase concentrations and neutrophil count in the lower uterine segment. , 1999, Human reproduction.
[251] C. Meldrum,et al. The αvβ6 integrin induces gelatinase B secretion in colon cancer cells , 1999 .
[252] Quan Zhao,et al. Mitogen-activated Protein Kinase/ERK Kinase Kinases 2 and 3 Activate Nuclear Factor-κB through IκB Kinase-α and IκB Kinase-β* , 1999, The Journal of Biological Chemistry.
[253] S. Kaul,et al. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. , 1999, Circulation.
[254] A. Glasier,et al. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. , 1999, Human reproduction.
[255] L. Hudson,et al. Sustained Activation of the Mitogen-activated Protein Kinase Pathway , 1999, The Journal of Biological Chemistry.
[256] W. Sanger,et al. Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha. , 1999, International Journal of Oncology.
[257] M. Cuzner,et al. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system , 1999, Journal of Neuroimmunology.
[258] T. Thompson,et al. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. , 1999, Molecular biology of the cell.
[259] J. Palace,et al. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. , 1999, Brain : a journal of neurology.
[260] K. Tanabe,et al. Involvement of CD44 in matrix metalloproteinase‐2 regulation in human melanoma cells , 1999, International journal of cancer.
[261] Everts,et al. CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts , 1999, Clinical and experimental immunology.
[262] T. Betsuyaku,et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1999, American journal of respiratory and critical care medicine.
[263] T. Betsuyaku,et al. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. , 1999, American journal of respiratory cell and molecular biology.
[264] T. Betsuyaku,et al. Gelatinase B deficiency does not protect against lipopolysaccharide-induced acute lung injury. , 1999, Chest.
[265] T. Ny,et al. Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation. , 1999, Endocrinology.
[266] F. Lee,et al. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta. , 1999, The Journal of biological chemistry.
[267] B. Coomber,et al. Production of gelatinases and tissue inhibitors of matrix metalloproteinases by equine ovarian stromal cells In vitro. , 1999, Biology of reproduction.
[268] I. Stamenkovic,et al. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. , 1999, Genes & development.
[269] C. Meldrum,et al. The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells. , 1999, International journal of cancer.
[270] A. Kugler. Matrix metalloproteinases and their inhibitors. , 1999, Anticancer research.
[271] B. Aggarwal,et al. Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. , 1999, FEBS letters.
[272] P. Courtoy,et al. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. , 1999, European journal of biochemistry.
[273] T. Hökfelt,et al. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[274] H. Larjava,et al. MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? , 1998, Biochemical and biophysical research communications.
[275] R. Pierce,et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. , 1998, Journal of immunology.
[276] Y. Sun,et al. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. , 1998, Journal of immunology.
[277] D. Lovett,et al. A Synergistic Interaction of Transcription Factors AP2 and YB-1 Regulates Gelatinase A Enhancer-dependent Transcription* , 1998, The Journal of Biological Chemistry.
[278] P. Koolwijk,et al. A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels. , 1998, Matrix biology : journal of the International Society for Matrix Biology.
[279] L. Kappos,et al. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. , 1998, Brain : a journal of neurology.
[280] D. Crowe,et al. alpha2beta1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity. , 1998, International journal of oncology.
[281] R. Dwek,et al. Oligosaccharides of recombinant mouse gelatinase B variants. , 1998, Biochimica et biophysica acta.
[282] G. Murray,et al. Human matrix metalloproteinase-9: activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form. , 1998, European journal of biochemistry.
[283] R. Clark,et al. The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[284] Z. Shao,et al. Genistein exerts multiple suppressive effects on human breast carcinoma cells. , 1998, Cancer research.
[285] S. Weiss,et al. Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.
[286] P. Libby,et al. Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing , 1998, The Journal of Immunology.
[287] A. Eisen,et al. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome. , 1998, Matrix biology : journal of the International Society for Matrix Biology.
[288] T. Thompson,et al. Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines. , 1998, Cancer research.
[289] S. Lorenzl,et al. Matrix metalloproteinases contribute to the blood—brain barrier disruption during bacterial meningitis , 1998, Annals of neurology.
[290] L. Wahl,et al. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. , 1998, Journal of immunology.
[291] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[292] M. d’Ortho,et al. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. , 1998, Journal of cell science.
[293] A. Newby,et al. Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB , 1998, FEBS letters.
[294] F. Goebel,et al. Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. , 1998, The Journal of infectious diseases.
[295] M. Quintanilla,et al. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[296] L. Feng,et al. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.
[297] Y. Okada,et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. , 1998, Journal of neuropathology and experimental neurology.
[298] Q. Sang,et al. Complex role of matrix metalloproteinases in angiogenesis , 1998, Cell Research.
[299] J. Sznajder,et al. Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. , 1998, The American journal of pathology.
[300] H. Takeuchi,et al. Involvement of proteasomes in migration and matrix metalloproteinase‐9 production of oral squamous cell carcinoma , 1998, International journal of cancer.
[301] F. Morel,et al. Human B Lymphocytes Synthesize the 92-kDa Gelatinase, Matrix Metalloproteinase-9* , 1998, The Journal of Biological Chemistry.
[302] C. Overall,et al. The Involvement of the Fibronectin Type II-like Modules of Human Gelatinase A in Cell Surface Localization and Activation* , 1998, The Journal of Biological Chemistry.
[303] Z. Werb,et al. Gelatinase B–deficient Mice Are Resistant to Experimental Bullous Pemphigoid , 1998, The Journal of experimental medicine.
[304] U. Shankavaram,et al. Lipopolysaccharide induction of monocyte matrix metalloproteinases is regulated by the tyrosine phosphorylation of cytosolic phospholipase A2 , 1998, Journal of leukocyte biology.
[305] L. Hudson,et al. Epidermal growth factor (EGF)‐ and scatter factor/hepatocyte growth factor (SF/HGF)‐mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)‐9 , 1998, Journal of cellular physiology.
[306] V. Kähäri,et al. Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro. , 1998, Matrix biology : journal of the International Society for Matrix Biology.
[307] S. Maśliński,et al. Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of gelatinase B (MMP-9) from human neutrophils , 1998, Inflammation Research.
[308] K. Fujikawa,et al. The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor , 1998, International journal of cancer.
[309] T. Nishikawa,et al. Differential Regulation of MMP-2 and MMP-9 Gelatinases in Cultured Human Keratinocytes , 1998, Dermatology.
[310] T. Kobayashi,et al. A Case of Anaphylactoid Purpura with Multiple Blister Formation: Possible Pathophysiological Role of Gelatinase (MMP-9) , 1998, Dermatology.
[311] Y. Okada,et al. TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.
[312] Z. Galis,et al. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? , 1998, Circulation.
[313] C. Confavreux,et al. Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV‐1 infected patients with tropical spastic paraparesis , 1998, Neurology.
[314] G. Opdenakker,et al. Gelatinase B in proliferative vitreoretinal disorders. , 1998, American journal of ophthalmology.
[315] A. Harf,et al. Cell-matrix interactions modulate 92-kD gelatinase expression by human bronchial epithelial cells. , 1998, American journal of respiratory cell and molecular biology.
[316] Raymond Sawaya,et al. Induction of Matrix Metalloproteinase-9 Requires a Polymerized Actin Cytoskeleton in Human Malignant Glioma Cells* , 1998, The Journal of Biological Chemistry.
[317] Y. St-Pierre,et al. In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators. , 1998, Biochimica et biophysica acta.
[318] E. Huberman,et al. Fibronectin-mediated Cell Adhesion Is Required for Induction of 92-kDa Type IV Collagenase/Gelatinase (MMP-9) Gene Expression during Macrophage Differentiation , 1998, The Journal of Biological Chemistry.
[319] G. Opdenakker,et al. Regulation of gelatinase B (MMP‐9) in leukocytes by plant lectins , 1998, FEBS letters.
[320] G. Rosenberg,et al. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[321] T. Haas,et al. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. , 1998, The Journal of biological chemistry.
[322] Gabriele Bergers,et al. MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.
[323] R. Fridman,et al. High Affinity Binding of Latent Matrix Metalloproteinase-9 to the α2(IV) Chain of Collagen IV* , 1998, The Journal of Biological Chemistry.
[324] H. Pfister,et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid , 1998, Journal of Neuroimmunology.
[325] H. Hartung,et al. Matrix metalloproteinases MMP‐9 and MMP‐7 are expressed in experimental autoimmune neuritis and the guillain‐barré syndrome , 1998, Annals of neurology.
[326] E. Ohuchi,et al. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. , 1998, European journal of biochemistry.
[327] B. Morrey,et al. Histologic and biochemical differences between osteolytic and nonosteolytic membranes around femoral components of an uncemented total hip arthroplasty. , 1998, The Journal of arthroplasty.
[328] A. Galloway,et al. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. , 1998, The Journal of surgical research.
[329] F. Aoudjit,et al. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. , 1998, Journal of immunology.
[330] D. Boyd,et al. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. , 1998, Cancer research.
[331] W. Scherbaum,et al. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. , 1998, Thyroid : official journal of the American Thyroid Association.
[332] S. Yagel,et al. Expression of gelatinase B by trophoblast cells: down-regulation by progesterone. , 1998, American journal of obstetrics and gynecology.
[333] S. Mizutani,et al. Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. , 1998, Cancer research.
[334] M. Klempner,et al. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis , 1998, Cancer.
[335] R. Hughes,et al. Matrix metalloproteinase expression during experimental autoimmune neuritis. , 1998, Brain : a journal of neurology.
[336] S. Itohara,et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. , 1998, Cancer research.
[337] C. Koch,et al. Studies of type IV collagenase regulation by hypoxia. , 1998, Cancer letters.
[338] H. Chung,et al. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells , 1998, Oncogene.
[339] A. Steere,et al. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. , 1998, The Journal of infectious diseases.
[340] D. Goldenberg,et al. Septic arthritis , 1998, The Lancet.
[341] M. Stack,et al. Intact Vitronectin Induces Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinases-2 Expression and Enhanced Cellular Invasion by Melanoma Cells* , 1998, The Journal of Biological Chemistry.
[342] J. Uhm,et al. Oligodendrocytes utilize a matrix metalloproteinase, MMP‐9, to extend processes along an astrocyte extracellular matrix , 1998, Glia.
[343] H. E. Wart,et al. Substrate Specificity and Mechanisms of Substrate Recognition of the Matrix Metalloproteinases , 1998 .
[344] P. Proost,et al. Interleukin-8 and other CXC chemokines , 1998 .
[345] G. Amorino,et al. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. , 1998, The American journal of pathology.
[346] R. Dwek,et al. Concepts and principles of O-linked glycosylation. , 1998, Critical reviews in biochemistry and molecular biology.
[347] E. Huberman,et al. Autocrine regulation of macrophage differentiation and 92-kDa gelatinase production by tumor necrosis factor-alpha via alpha5 beta1 integrin in HL-60 cells. , 1998, The Journal of biological chemistry.
[348] R. Cardiff,et al. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. , 1998, Journal of cellular physiology.
[349] S. Barondes,et al. X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution. , 1998, The Journal of biological chemistry.
[350] D. Fishman,et al. Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen. , 1998, Invasion & metastasis.
[351] F. Lottspeich,et al. Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1. , 1998, Leukemia.
[352] A. Reiner,et al. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. , 1998, Microvascular research.
[353] U. Shankavaram,et al. Regulation of human monocyte matrix metalloproteinases by SPARC , 1997, Journal of cellular physiology.
[354] R. Fridman,et al. Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2* , 1997, The Journal of Biological Chemistry.
[355] B. C. Patterson,et al. Angiostatin-converting Enzyme Activities of Human Matrilysin (MMP-7) and Gelatinase B/Type IV Collagenase (MMP-9)* , 1997, The Journal of Biological Chemistry.
[356] J. Voorhees,et al. Pathophysiology of premature skin aging induced by ultraviolet light. , 1997, The New England journal of medicine.
[357] Y. Sun,et al. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter , 1997, Molecular and cellular biology.
[358] F. Orr,et al. Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[359] J. Bousquet,et al. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. , 1997, American journal of respiratory cell and molecular biology.
[360] K. Yamada,et al. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. , 1997, Journal of immunology.
[361] V. Perry,et al. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke , 1997, Neuropathology and applied neurobiology.
[362] D. Gomez,et al. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.
[363] H. Chapman,et al. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. , 1997, Current opinion in cell biology.
[364] J. Buhler,et al. Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1beta and TNF-alpha. , 1997, The American journal of physiology.
[365] J. Buhler,et al. Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1β and TNF-α. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[366] G. Tuszynski,et al. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. , 1997, Experimental cell research.
[367] P. Libby,et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? , 1997, Circulation research.
[368] C. López-Otín,et al. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). , 1997, European journal of biochemistry.
[369] C. Wolf‐Peeters,et al. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. , 1997, The American journal of pathology.
[370] G. Serio,et al. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. , 1997, European journal of cancer.
[371] U. Bergmann,et al. Activation of Type IV Procollagenases by Human Tumor-associated Trypsin-2* , 1997, The Journal of Biological Chemistry.
[372] R. Bataille,et al. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. , 1997, Blood.
[373] S. Spiegel,et al. Calcium influx inhibits MT1‐MMP processing and blocks MMP‐2 activation , 1997, FEBS letters.
[374] M. Grisham,et al. Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. , 1997, The American journal of physiology.
[375] J. Dequeker,et al. Gelatinase B in chronic synovitis: immunolocalization with a monoclonal antibody. , 1997, British journal of rheumatology.
[376] C. Overall,et al. Specific, High Affinity Binding of Tissue Inhibitor of Metalloproteinases-4 (TIMP-4) to the COOH-terminal Hemopexin-like Domain of Human Gelatinase A , 1997, The Journal of Biological Chemistry.
[377] H. Miyake,et al. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. , 1997, The Journal of urology.
[378] G. Opdenakker,et al. Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia. , 1997, Cytokine.
[379] R. Copeland,et al. Recombinant human 92-kDa type IV collagenase/gelatinase from baculovirus-infected insect cells: expression, purification, and characterization. , 1997, Protein expression and purification.
[380] P. Phillips,et al. Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts. , 1997, The American journal of physiology.
[381] Kenneth M. Yamada,et al. Modulation of MMP‐2 (gelatinase A) and MMP‐9 (gelatinase B) by interferon‐γ in a human salivary gland cell line , 1997, Journal of cellular physiology.
[382] C. Bucana,et al. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. , 1997, The American journal of pathology.
[383] J. Woessner,et al. Role of metalloproteinases in the development and healing of acetic acid-induced gastric ulcer in rats. , 1997, Scandinavian journal of gastroenterology.
[384] R. Muschel,et al. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line , 1997, Oncogene.
[385] F. Kikkawa,et al. c‐Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells , 1997, FEBS letters.
[386] F. Thaiss,et al. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. , 1997, Kidney international.
[387] R. Ohira,et al. An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1). , 1997, Biology of reproduction.
[388] J. Garibay-Tupas,et al. An autocrine/paracrine role of human decidual relaxin. I. Interstitial collagenase (matrix metalloproteinase-1) and tissue plasminogen activator. , 1997, Biology of reproduction.
[389] J. Cossins,et al. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor , 1997, Journal of Neuroimmunology.
[390] M. Cobb,et al. Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.
[391] M. Cullen,et al. Matrix Metalloproteinases in Dog Brains Exhibiting Alzheimer‐Like Characteristics , 1997, Journal of neurochemistry.
[392] D. Falcone,et al. Role of Laminin in Matrix Induction of Macrophage Urokinase-type Plasminogen Activator and 92-kDa Metalloproteinase Expression* , 1997, The Journal of Biological Chemistry.
[393] E. Lengyel,et al. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades , 1997, Oncogene.
[394] A. Aplin,et al. Integrin-mediated Activation of MAP Kinase Is Independent of FAK: Evidence for Dual Integrin Signaling Pathways in Fibroblasts , 1997, The Journal of cell biology.
[395] R. Fridman,et al. Epidermal growth factor and amphiregulin up‐regulate matrix metalloproteinase‐9 (MMP‐9) in human breast cancer cells , 1997, International journal of cancer.
[396] T. Vu,et al. Gelatinase A Activation Is Regulated by the Organization of the Polymerized Actin Cytoskeleton* , 1997, The Journal of Biological Chemistry.
[397] H. Emonard,et al. Binding of 92 kDa and 72 kDa Progelatinases to Insoluble Elastin Modulates Their Proteolytic Activation , 1997, Biological chemistry.
[398] U. Gullberg,et al. Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development , 1997, European journal of haematology.
[399] C. Brinckerhoff,et al. The AP-1 site and MMP gene regulation: what is all the fuss about? , 1997, Matrix biology : journal of the International Society for Matrix Biology.
[400] T. Stephenson,et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. , 1997, Journal of immunology.
[401] M. Belin,et al. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes , 1997, Molecular Psychiatry.
[402] G. Opdenakker,et al. Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration. , 1997, European journal of biochemistry.
[403] H. Kolkenbrock,et al. Activation of Progelatinase A and Progelatinase A/TIMP-2 Complex by Membrane Type 2-Matrix Metalloproteinase , 1997, Biological chemistry.
[404] E. Canalis,et al. Transforming growth factor β1 inhibits collagenase 3 expression by transcriptional and post‐transcriptional mechanisms in osteoblast cultures , 1997 .
[405] G. Ferry,et al. Activation of MMP‐9 by neutrophil elastase in an in vivo model of acute lung injury , 1997, FEBS letters.
[406] H. Sato,et al. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin , 1997, FEBS Letters.
[407] D. Faller,et al. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat. , 1997, Virology.
[408] Y. Seyama,et al. Anti‐α3 integrin antibody induces the activated form of matrix metalloprotease‐2 (MMP‐2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells , 1997, International journal of cancer.
[409] B. Toole,et al. Stimulation of Matrix Metalloproteinase Production by Recombinant Extracellular Matrix Metalloproteinase Inducer from Transfected Chinese Hamster Ovary Cells* , 1997, The Journal of Biological Chemistry.
[410] Y. Kodera,et al. Plasma concentration of matrix metalloproteinase 9 in gastric cancer , 1997, The British journal of surgery.
[411] G. Sutton,et al. Collagenase expression in ovarian cancer cell lines. , 1995, Gynecologic oncology.
[412] R. Dwek,et al. Glycosylation: heterogeneity and the 3D structure of proteins. , 1997, Critical reviews in biochemistry and molecular biology.
[413] B. Zimmermann,et al. Substance P Induces the Secretion of Gelatinase A from Human Synovial Fibroblasts , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[414] N. Copeland,et al. Matrix metalloproteinase-9 maps to the distal end of chromosome 2 in the mouse. , 1997, Developmental genetics.
[415] Michael J. Cullen,et al. Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-β Peptide (1–40) , 1996, The Journal of Neuroscience.
[416] J. Uhm,et al. Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9 , 1996 .
[417] G. Opdenakker,et al. Flow cytometric analysis of gelatinase B (MMP-9) activity using immobilized fluorescent substrate on microspheres. , 1996, Cytometry.
[418] E. Waubant,et al. Interferon beta‐1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis , 1996, Annals of neurology.
[419] G. Schultz,et al. Tissue inhibitor of metalloproteinases‐3 is the major metalloproteinase inhibitor in the decidualizing murine uterus , 1996, Molecular reproduction and development.
[420] J. Newcombe,et al. The Expression of Tissue‐type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis: Comparison of Stages in Lesion Evolution , 1996, Journal of neuropathology and experimental neurology.
[421] D. Harrison,et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.
[422] J. Harb,et al. Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases. , 1996, Cancer research.
[423] D. Rappolee,et al. Basement Membrane and Repair of Injury to Peripheral Nerve: Defining a Potential Role for Macrophages, Matrix Metalloproteinases, and Tissue Inhibitor of Metalloproteinases-1 , 1996, The Journal of experimental medicine.
[424] B. Weeks,et al. bFGF stimulates U937 cell adhesion to fibronectin and secretion of gelatinase B. , 1996, Biochemical and biophysical research communications.
[425] P. Kovanen,et al. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. , 1996, Journal of immunology.
[426] M. Lotze,et al. Suppression of prostaglandin H synthase-2 induction in human monocytes by in vitro or in vivo administration of interleukin 4. , 1996, Cellular immunology.
[427] J. Rubin,et al. Mechanisms of Hepatocyte Growth Factor Stimulation of Keratinocyte Metalloproteinase Production* , 1996, The Journal of Biological Chemistry.
[428] G. Nuovo,et al. Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. , 1996, Arthritis and rheumatism.
[429] N. Haites,et al. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. , 1996, European journal of cancer.
[430] C. He,et al. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. , 1996, Cancer letters.
[431] H. Sato,et al. Activation of a recombinant membrane type 1‐matrix metalloproteinase (MT1‐MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)‐2 , 1996, FEBS letters.
[432] S. Kapila,et al. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. , 1996, Matrix biology : journal of the International Society for Matrix Biology.
[433] A. Koch,et al. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. , 1996, Arthritis and rheumatism.
[434] M. Takigawa,et al. Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. , 1996, Endocrinology.
[435] G. Rice,et al. Pharmacological inhibition of gelatinase B induction and tumor cell invasion , 1996, International journal of cancer.
[436] P. Suter,et al. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.
[437] B. Mclaughlin,et al. Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72 kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis. , 1996, The Biochemical journal.
[438] C. López-Otín,et al. Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation , 1996, The Journal of Biological Chemistry.
[439] E. Roets,et al. The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. , 1996, Biochemical pharmacology.
[440] C. Miller,et al. Matrix Metalloproteinases in the Neocortex and Spinal Cord of Amyotrophic Lateral Sclerosis Patients , 1996, Journal of neurochemistry.
[441] D. Hume,et al. Endotoxin signal transduction in macrophages , 1996, Journal of leukocyte biology.
[442] I. Zvibel,et al. DISRUPTION OF CELL—CELL ADHESION IN THE PRESENCE OF SODIUM BUTYRATE ACTIVATES EXPRESSION OF THE 92kDa TYPE IV COLLAGENASE IN MDCK CELLS , 1996, Cell biology international.
[443] S. Kumar,et al. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy. , 1996, Journal of molecular and cellular cardiology.
[444] J. Buhler,et al. Expression of Matrix Metalloproteinase Gelatinases A and B by Cultured Epithelial Cells from Human Bronchial Explants* , 1996, The Journal of Biological Chemistry.
[445] S. Eccles,et al. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). , 1996, Cancer research.
[446] Z. Gokaslan,et al. Modulation of matrix metalloprotease-2 and invasion in human glioma cells by α3β1 integrin , 1996 .
[447] C. Ford,et al. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis , 1996, Neurology.
[448] M. Flannery,et al. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. , 1996, Development.
[449] P. Kiener,et al. Activation of human monocytes through CD40 induces matrix metalloproteinases. , 1996, Journal of immunology.
[450] E. Lengyel,et al. Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences (*) , 1996, The Journal of Biological Chemistry.
[451] D. Woolley,et al. Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. , 1996, Journal of reproduction and fertility.
[452] Gary A. Rosenberg,et al. Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[453] A. Vaheri,et al. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. , 1996, The Journal of investigative dermatology.
[454] N. Seidah,et al. Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases. , 1996, The Biochemical journal.
[455] G. Opdenakker,et al. Gelatinase A secretion and its control in peritubular and Sertoli cell cultures: effects of hormones, second messengers and inducers of cytokine production , 1996, Molecular and Cellular Endocrinology.
[456] K. Somasundaram,et al. Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[457] P. Gottschall,et al. Increased Production of Matrix Metalloproteinases in Enriched Astrocyte and Mixed Hippocampal Cultures Treated with β‐Amyloid Peptides , 1996 .
[458] J. Strauss,et al. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. , 1996, American journal of obstetrics and gynecology.
[459] L. Windsor,et al. Activation of human progelatinase A by collagenase and matrilysin: Activation of procollagenase by matrilysin , 1996, Journal of protein chemistry.
[460] S. Lazarus,et al. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. , 1996, The Journal of clinical investigation.
[461] Y. Okada,et al. Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co‐culture of human osteosarcoma cells and human fibroblasts: Gelatinase‐B production was stimulated via up‐regulation of fibroblast growth factor (FGF) receptor , 1996, International journal of cancer.
[462] H. Flad,et al. TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. , 1996, Journal of immunology.
[463] A. Yuo,et al. Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release. , 1996, Experimental hematology.
[464] R. Sobel,et al. Matrix Metalloproteinases in the Normal Human Central Nervous System, Microglial Nodules, and Multiple Sclerosis Lesions , 1996, Journal of neuropathology and experimental neurology.
[465] C. Delacourt,et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. , 1996, American journal of respiratory cell and molecular biology.
[466] W. Rom,et al. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. , 1996, Thorax.
[467] Y. Okada,et al. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas , 1996, International journal of cancer.
[468] I. Hewlett,et al. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. , 1996, Journal of immunology.
[469] W. Couser,et al. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. , 1996, The Journal of clinical investigation.
[470] G. Opdenakker,et al. Synergistic and selective stimulation of gelatinase B production in macrophages by lipopolysaccharide, trans-retinoic acid and CGP 41251, a protein kinase C regulator. , 1996, Biochimica et biophysica acta.
[471] G. Nuovo,et al. Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker. , 1996, Clinical immunology and immunopathology.
[472] J. Zahm,et al. Gelatinase B is involved in the in vitro wound repair of human respiratory epithelium , 1996, Journal of cellular physiology.
[473] M. Seiki,et al. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. , 1996, The American journal of pathology.
[474] S. Zucker,et al. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[475] P. Singhal,et al. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. , 1996, Biochemical and biophysical research communications.
[476] J. Voorhees,et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism , 1996, Nature.
[477] B. Nielsen,et al. 92 kDa type IV collagenase (MMP‐9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer , 1996, International journal of cancer.
[478] K. Takeda,et al. Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion. , 1996, Cancer letters.
[479] M. Kitamura,et al. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. , 1996, The American journal of physiology.
[480] Schroen Dj,et al. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. , 1996 .
[481] L. Matrisian,et al. Complex roles of matrix metalloproteinases in tumor progression. , 1996, Current topics in microbiology and immunology.
[482] T. Sato,et al. Tumor necrosis factor alpha (TNFalpha) induces pro-matrix metalloproteinase 9 production in human uterine cervical fibroblasts but interleukin 1alpha antagonizes the inductive effect of TNFalpha. , 1996, FEBS letters.
[483] V. Leblond,et al. Production of type IV collagen and 72-kDa gelatinase by human endothelial cells cultured in high glucose. Effects of a protein kinase C inhibitor, GF 109203X. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[484] S. Hauser,et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. , 1996, Journal of immunology.
[485] T. Haas,et al. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[486] W. Stetler-Stevenson,et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. , 1996, Cell.
[487] J. Uhm,et al. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. , 1996, Clinical & experimental metastasis.
[488] M. Reidy,et al. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. , 1996, Circulation research.
[489] W. T. Chen,et al. A mechanism for regulation of melanoma invasion. Ligation of alpha6beta1 integrin by laminin G peptides. , 1996, The Journal of biological chemistry.
[490] Z. Gokaslan,et al. Modulation of matrix metalloprotease-2 and invasion in human glioma cells by alpha 3 beta 1 integrin. , 1996, Cancer letters.
[491] G. Murphy,et al. Activation of human neutrophil procollagenase by stromelysin 2. , 1996, European journal of biochemistry.
[492] William G. Stetler-Stevenson,et al. Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window , 1995, Brain Research.
[493] G. Opdenakker,et al. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity. , 1995, European journal of biochemistry.
[494] J. Dayer,et al. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. , 1995, The Journal of clinical investigation.
[495] C. Delacourt,et al. Tachykinins induce gelatinase production by guinea pig alveolar macrophages: involvement of NK2 receptors. , 1995, The American journal of physiology.
[496] S. Hauser,et al. Stimulation of matrix metalloproteinase‐dependent migration of T cells by eicosanoids , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[497] Y. Watanabe,et al. Characterization of gelatinases in human placenta. , 1995, Biochemical and molecular medicine.
[498] Hiroshi Sato,et al. Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library , 1995, The Journal of Biological Chemistry.
[499] I. Pucci‐Minafra,et al. Cell‐cell and cell‐collagen interactions influence gelatinase production by human breast‐carcinoma cell line 8701‐BC , 1995, International journal of cancer.
[500] R. Kerbel,et al. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. , 1995, Cancer research.
[501] H. Birkedal‐Hansen,et al. Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. , 1995, Biochimica et biophysica acta.
[502] R. Muschel,et al. MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization. , 1995, Brain research. Developmental brain research.
[503] J. Gershenwald,et al. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. , 1995, Cancer research.
[504] A. Pollock,et al. Tissue-specific Enhancer-Promoter Interactions Regulate High Level Constitutive Expression of Matrix Metalloproteinase 2 by Glomerular Mesangial Cells (*) , 1995, The Journal of Biological Chemistry.
[505] H. Friess,et al. Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer , 1995, International journal of cancer.
[506] Y. Itoh,et al. Steps Involved in Activation of the Pro-matrix Metalloproteinase 9 (Progelatinase B)-Tissue Inhibitor of Metalloproteinases-1 Complex by 4-Aminophenylmercuric Acetate and Proteinases (*) , 1995, The Journal of Biological Chemistry.
[507] T. Pourmotabbed,et al. Mechanism of Activation of Human Neutrophil Gelatinase B , 1995, The Journal of Biological Chemistry.
[508] J. Strauss,et al. 92-kDa gelatinase (matrix metalloproteinase-9) is induced in rat amnion immediately prior to parturition. , 1995, Biology of reproduction.
[509] J. Furuyama,et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. , 1995, Journal of neurosurgery.
[510] C. Delacourt,et al. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.
[511] L. Cornelius,et al. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. , 1995, The Journal of investigative dermatology.
[512] J. Powell,et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[513] W. Pearce,et al. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[514] H. Sato,et al. Complex Regulation of Membrane-type Matrix Metalloproteinase Expression and Matrix Metalloproteinase-2 Activation by Concanavalin a in Mda-mb-231 Human Breast Cancer Cells1 Activation of Which Has Been Associated with Metastatic Progression in Human Breast Cancer (hbc). Concanavalin a (con A) Has Be , 2022 .
[515] M. J. Banda,et al. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix. , 1995, Biochemistry.
[516] P. Barker,et al. Binding of gelatinases A and B to type-I collagen and other matrix components. , 1995, The Biochemical journal.
[517] Y. Ito,et al. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. , 1995, Cancer research.
[518] U. Puistola,et al. Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells. , 1995, Fertility and sterility.
[519] P. Libby,et al. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[520] R. Mecham,et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. , 1995, The Journal of clinical investigation.
[521] R. Fridman,et al. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). , 1995, Cancer research.
[522] D. Faller,et al. The Moloney Leukemia Retroviral Long Terminal Repeat trans-Activates AP-1-inducible Genes and AP-1 Transcription Factor Binding (*) , 1995, The Journal of Biological Chemistry.
[523] R. Kerbel,et al. Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape. , 1995, Experimental cell research.
[524] Stephen J. Weiss,et al. Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.
[525] H. Kleinman,et al. Laminin SIKVAV Peptide Induction of Monocyte/Macrophage Prostaglandin E and Matrix Metalloproteinases (*) , 1995, The Journal of Biological Chemistry.
[526] E. Waubant,et al. T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.
[527] B. Verrier,et al. Induction of MMP9 (92 kDa Gelatinase) Activity and Expression of Tissue In hibitor of Metalloproteinase‐2 mRNA (TIMP‐2) in Primitive Neuroectodermal Cells Infected with Retrovirus HTLV‐I , 1995, The European journal of neuroscience.
[528] Z. Werb,et al. Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin , 1995, The Journal of cell biology.
[529] J. Isner,et al. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. , 1995, Circulation.
[530] J. Brugge,et al. Integrins and signal transduction pathways: the road taken. , 1995, Science.
[531] T. Noumi,et al. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. , 1995, Oncogene.
[532] B. Olsen,et al. 92‐kDa type IV collagenase and TIMP‐3, but not 72‐kDa type IV collagenase or TIMP‐1 or TIMP‐2, are highly expressed during mouse embryo implantation , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.
[533] W. Rath,et al. Biochemical events in cervical ripening dilatation during pregnancy and parturition. , 1995, Journal of obstetrics and gynaecology.
[534] G. Schultz,et al. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. , 1995, Development.
[535] S. De Flora,et al. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N‐acetylcysteine , 1995, International journal of cancer.
[536] K. Imai,et al. Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma Cells , 1995, The Journal of Biological Chemistry.
[537] R. Mecham,et al. Activation of the 92-kDa Gelatinase by Stromelysin and 4-Aminophenylmercuric Acetate , 1995, The Journal of Biological Chemistry.
[538] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[539] F. Breedveld,et al. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. , 1995, The Journal of rheumatology.
[540] L. Mahadevan,et al. Parallel signal processing among mammalian MAPKs. , 1995, Trends in biochemical sciences.
[541] Z. Tökés,et al. The 84‐kDa Form of Human Matrix Metalloproteinase‐9 Degrades Substance P and Gelatin , 1995, Journal of neurochemistry.
[542] M. Longaker,et al. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. , 1995, The Journal of investigative dermatology.
[543] H. Baylis,et al. Infection with Theileria annulata induces expression of matrix metalloproteinase 9 and transcription factor AP-1 in bovine leucocytes. , 1995, Molecular and biochemical parasitology.
[544] F. Kikkawa,et al. Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta. , 1995, American journal of obstetrics and gynecology.
[545] D. Steed,et al. Characterization of a dinucleotide repeat in the 92 kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease , 1995, Annals of human genetics.
[546] S. Shapiro,et al. Agonist-induced expression of tissue inhibitor of metalloproteinases and metalloproteinases by human macrophages is regulated by endogenous prostaglandin E2 synthesis. , 1995, The Journal of investigative dermatology.
[547] Y. Okada,et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[548] G Murphy,et al. Tissue inhibitors of matrix metalloendopeptidases. , 1995, Methods in enzymology.
[549] H. Tschesche. Human neutrophil collagenase. , 1995, Methods in enzymology.
[550] E. Furth,et al. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. , 1995, The American journal of pathology.
[551] J. Foidart,et al. Modulation of the expression of interstitial and type-IV collagenases in coculture of HT1080 fibrosarcoma cells and fibroblasts. , 1995, Invasion & metastasis.
[552] M. Yoshida,et al. Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. , 1995, Journal of inflammation.
[553] H. Schnaper,et al. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. , 1995, Journal of immunology.
[554] K. Suzuki,et al. Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II. , 1995, The Biochemical journal.
[555] P. Libby,et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[556] S. Shapiro,et al. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. , 1994, American journal of respiratory and critical care medicine.
[557] L. Steinman,et al. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. , 1994, The Journal of clinical investigation.
[558] L. Liotta,et al. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. , 1994, Biochemistry.
[559] D. Dormont,et al. Modulations of 92kDa gelatinase B and its inhibitors are associated with HIV-1 infection in human macrophage cultures. , 1994, Biochemical and biophysical research communications.
[560] F. Grinnell,et al. Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. , 1994, The Journal of investigative dermatology.
[561] M. Ågren,et al. Gelatinase activity during wound healing , 1994, The British journal of dermatology.
[562] R. Senior,et al. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin. , 1994, Biochemical and biophysical research communications.
[563] R. Sepper,et al. Gelatinolytic and type IV collagenolytic activity in bronchiectasis. , 1994, Chest.
[564] J. Dayer,et al. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. , 1994, The Journal of biological chemistry.
[565] C. Azuma,et al. Type‐IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues , 1994, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[566] G. Opdenakker,et al. Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases , 1994, Journal of Neuroimmunology.
[567] L. Liotta,et al. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[568] J. Knowlden,et al. Identification and independent regulation of human mesangial cell metalloproteinases. , 1994, Kidney international.
[569] M. Reidy,et al. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. , 1994, Circulation research.
[570] W. Stetler-Stevenson,et al. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. , 1994, The Journal of biological chemistry.
[571] A. H. Drummond,et al. Processing of tumour necrosis factor-α precursor by metalloproteinases , 1994, Nature.
[572] T. Turpeenniemi‐Hujanen,et al. Modulation of Mr 72,000 and Mr 92,000 type‐IV collagenase (gelatinase A and B) gene expression by interferons alpha and gamma in human melanoma , 1994, International journal of cancer.
[573] T. Tsuruo,et al. Human recombinant interferons‐beta and ‐gamma decrease gelatinase production and invasion by human KG‐2 renal‐carcinoma cells , 1994, International journal of cancer.
[574] H. Larjava,et al. Matrix Metalloproteinases (MMP-2 and MMP-9) of the Oral Cavity: Cellular Origin and Relationship to Periodontal Status , 1994, Journal of dental research.
[575] D. Eyre,et al. A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen. , 1994, Biochemical and biophysical research communications.
[576] P. Kovanen,et al. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. , 1994, The Journal of biological chemistry.
[577] S. Martin,et al. Structure of baby hamster kidney carbohydrate-binding protein CBP30, an S-type animal lectin. , 1994, The Journal of biological chemistry.
[578] G. Zeng,et al. Expression of 72-kDa gelatinase and TIMP-2 in early and late passage human fibroblasts. , 1994, Experimental cell research.
[579] Y. Soini,et al. 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[580] P. Libby,et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.
[581] P. Petrides,et al. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. , 1994, Blood.
[582] A. M. Romanic,et al. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent , 1994, The Journal of cell biology.
[583] J. O'Connell,et al. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. , 1994, The Journal of biological chemistry.
[584] J. O'Connell,et al. Human progelatinase A can be activated by matrilysin , 1994, FEBS letters.
[585] S. Gruber,et al. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[586] M A Moses,et al. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). , 1994, The Journal of biological chemistry.
[587] W. Parks,et al. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. , 1994, The Journal of clinical investigation.
[588] C. Bucana,et al. Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells. , 1994, American Journal of Pathology.
[589] W. Stetler-Stevenson,et al. Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes. , 1994, Archives of biochemistry and biophysics.
[590] A. Clowes,et al. Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. , 1994, The Journal of clinical investigation.
[591] W. Stetler-Stevenson,et al. Quantitative zymography: detection of picogram quantities of gelatinases. , 1994, Analytical biochemistry.
[592] W. Stetler-Stevenson,et al. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[593] I. Fidler,et al. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. , 1994, Journal of immunology.
[594] R. Poorman,et al. Interstitial collagenase is required for angiogenesis in vitro. , 1994, Developmental biology.
[595] M. Cockett,et al. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. , 1994, The Journal of biological chemistry.
[596] J. Dayer,et al. 1,25-dihydroxyvitamin D3 dissociates production of interstitial collagenase and 92-kDa gelatinase in human mononuclear phagocytes. , 1994, The Journal of biological chemistry.
[597] C. Munaut,et al. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development , 1994, The Journal of cell biology.
[598] I. Lubensky,et al. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. , 1994, The American journal of pathology.
[599] R. Huber,et al. The X‐ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. , 1994, The EMBO journal.
[600] G. Opdenakker,et al. Cytokine-regulated proteases in autoimmune diseases. , 1994, Immunology today.
[601] R. Eckert,et al. Transforming Growth Factor β1 Regulation of Metalloproteinase Production in Cultured Human Cervical Epithelial Cells , 1994 .
[602] C. Bucana,et al. Regulation of Gelatinase Production in Metastatic Renal Cell Carcinoma by Organ‐specific Fibroblasts , 1994, Japanese journal of cancer research : Gann.
[603] H. Larjava,et al. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[604] E. Amento,et al. Interleukin-1 and transforming growth factor-alpha: synergistic stimulation of metalloproteinases, PGE2, and proliferation in human fibroblasts. , 1994, Experimental cell research.
[605] C. Bailey,et al. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. , 1994, Journal of clinical pathology.
[606] T. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.
[607] L. Liotta,et al. Induction of tissue‐type plasminogen activator and 72‐kDa type‐IV collagenase by ionizing radiation in rat astrocytes , 1994, International journal of cancer.
[608] E. Lehtonen,et al. Increased expression of the matrix metalloproteinase 2 in differentiating tera 2 human embryonal carcinoma cells , 1994, International journal of cancer.
[609] R. Rees,et al. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. , 1994, British Journal of Cancer.
[610] R. Muschel,et al. Metalloproteinases in tumor progression: the contribution of MMP-9. , 1994, Invasion & metastasis.
[611] M. Stearns,et al. Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: effects of taxol. , 1994, Oncology research.
[612] D. Lovett,et al. Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. , 1994, The American journal of pathology.
[613] R. Eckert,et al. Transforming Growth Factor 131 Regulation of Metalloproteinase Production in Cultured Human Cervical Epithelial Cells , 2007 .
[614] V. V. van Hinsbergh,et al. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. , 1993, The Biochemical journal.
[615] E. Bock,et al. Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[616] H. Schnaper,et al. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B) , 1993, Journal of cellular physiology.
[617] C. Soria,et al. Activation of the 92 kDa type IV collagenase by tissue kallikrein , 1993, Journal of cellular physiology.
[618] C. Ioannou,et al. Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. , 1993, European journal of biochemistry.
[619] C. Figdor,et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. , 1993, Journal of immunology.
[620] A. Hanby,et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. , 1993, Cancer research.
[621] H. Sato,et al. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. , 1993, The Journal of biological chemistry.
[622] G. Opdenakker,et al. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein , 1993, Journal of neuroscience research.
[623] G. Opdenakker,et al. Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation. , 1993, European journal of biochemistry.
[624] P. Roughley,et al. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. , 1993, The Biochemical journal.
[625] Y. DeClerck,et al. Direct activation of human neutrophil procollagenase by recombinant stromelysin. , 1993, The Biochemical journal.
[626] H. Birkedal‐Hansen,et al. Anti‐integrin antibodies induce type IV collagenase expression in keratinocytes , 1993, Journal of cellular physiology.
[627] T. Salo,et al. Expression of 72 kilodalton and 92 kilodalton type IV collagenase in malignant fibrous histiocytomas and dermatofibromas. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[628] Y. Tomino,et al. Gene expression of metalloproteinases and their inhibitor in renal tissue of New Zealand black/white F1 mice. , 1993, Clinical science.
[629] G. Nicolson,et al. Role and regulation of expression of 92‐kDa type‐IV collagenase (MMP‐9) in 2 invasive squamous‐cell‐carcinoma cell lines of the oral cavity , 1993, International journal of cancer.
[630] W. Parks,et al. Distinct mechanisms regulate interstitial collagenase and 92-kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. , 1993, The Journal of biological chemistry.
[631] H. Birkedal‐Hansen,et al. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. , 1993, The Journal of biological chemistry.
[632] H. Schnaper,et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro , 1993, Journal of cellular physiology.
[633] T. Salo,et al. Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. , 1993, The Journal of investigative dermatology.
[634] Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. , 1993, Cancer research.
[635] F. Grinnell,et al. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. , 1993, The Journal of investigative dermatology.
[636] W. Stetler-Stevenson,et al. Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. , 1993, The Journal of clinical investigation.
[637] H. Birkedal‐Hansen,et al. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). , 1993, Biochemistry.
[638] H. Zhou,et al. Induction of metalloproteinase activity in human T-lymphocytes. , 1993, Biochimica et biophysica acta.
[639] W. Stetler-Stevenson,et al. HIV-1 infection stimulates T cell invasiveness and synthesis of the 92-kDa type IV collagenase. , 1993, AIDS research and human retroviruses.
[640] J. Rhim,et al. Altered epidermal growth factor signal transduction in activated Ha-ras-transformed human keratinocytes. , 1993, Biochemical and biophysical research communications.
[641] H. Sengeløv,et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. , 1993, The Journal of biological chemistry.
[642] L. Liotta,et al. Elevated Levels of Mr 92,000 Type IV Collagenase in Human Brain Tumors , 1993 .
[643] S. Wahl,et al. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[644] G. Opdenakker,et al. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. , 1993, Biochemical and biophysical research communications.
[645] Wahl Lm,et al. REGULATION OF MONOCYTE/MACROPHAGE METALLOPROTEINASE PRODUCTION BY CYTOKINES , 1993 .
[646] H. Sabzevari,et al. Production and regulation of gelatinase B by human T-cells. , 1993, Biochimica et biophysica acta.
[647] S. Shapiro,et al. Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. , 1993, The Journal of biological chemistry.
[648] D. Lovett,et al. Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells. , 1993, The Biochemical journal.
[649] J. Hoidal,et al. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. , 1993, The Journal of clinical investigation.
[650] Y. Okada,et al. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. , 1993, Journal of cell science.
[651] Y. Sasaguri,et al. Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. , 1993, British Journal of Cancer.
[652] L. Kjeldsen,et al. Control of exocytosis in early neutrophil activation. , 1993, Journal of immunology.
[653] H. Tanaka,et al. Molecular cloning and expression of the mouse 105-kDa gelatinase cDNA. , 1993, Biochemical and Biophysical Research Communications - BBRC.
[654] H. Sato,et al. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. , 1993, Oncogene.
[655] C. Wolf‐Peeters,et al. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. , 1993, Journal of immunology.
[656] M. Ingelman-Sundberg,et al. Differential regulation of gelatinase b and tissue‐type plasminogen activator expression in human bowes melanoma cells , 1993, International journal of cancer.
[657] A. Eisen,et al. Localization of 92-kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin. , 1993, The Journal of investigative dermatology.
[658] L. Wahl,et al. Regulation of monocyte/macrophage metalloproteinase production by cytokines. , 1993, Journal of periodontology.
[659] U. Moll,et al. Mr 92,000 Type IV Collagenase Is Increased in Plasma of Patients with Colon Cancer and Breast Cancer , 1993 .
[660] V. Castronovo,et al. Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells. , 1993, Invasion & metastasis.
[661] M. Hendrix,et al. The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. , 1993, Cancer research.
[662] H. Birkedal‐Hansen,et al. Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[663] A. Kossakowska,et al. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. , 1993, Oncology research.
[664] L. Liotta,et al. Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.
[665] H. Tschesche,et al. A 25 kDa α2‐microglobulin‐related protein is a component of the 125 kDa form of human gelatinase , 1992, FEBS letters.
[666] P. Courtoy,et al. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[667] J. Lohi,et al. Pericellulars substrates of human mast cell tryptase: 72,000 Dalton gelatinase and fibronectin , 1992, Journal of cellular biochemistry.
[668] Y. Takada,et al. VLA‐4 Molecules on Tumor Cells Initiate an Adhesive Interaction with VCAM‐1 Molecules on Endothelial Cell Surface , 1992, Japanese journal of cancer research : Gann.
[669] C. Bucana,et al. Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice. , 1992, Differentiation; research in biological diversity.
[670] G. Goldberg,et al. Constitutive synthesis of a 92-kDa keratinocyte-derived type IV collagenase is enhanced by type I collagen and decreased by type IV collagen matrices. , 1992, The Journal of investigative dermatology.
[671] S Bord,et al. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. , 1992, Journal of cell science.
[672] G. Opdenakker,et al. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders , 1992, Journal of Neuroimmunology.
[673] K. Naka,et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. , 1992, The Journal of biological chemistry.
[674] W. Stetler-Stevenson,et al. Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast‐cancer cells , 1992, International journal of cancer.
[675] L. Kjeldsen,et al. Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules. , 1992, The Biochemical journal.
[676] T. Hardingham,et al. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. , 1992, The Journal of biological chemistry.
[677] H. Flad,et al. Recombinant tumor necrosis factor-alpha potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. , 1992, Journal of immunology.
[678] R. Ulrich,et al. Induction of neutral proteinase and prostanoid production in bovine nasal chondrocytes by interleukin-1 and tumor necrosis factor alpha: modulation of these cellular responses by interleukin-6 and platelet-derived growth factor. , 1992, Clinical immunology and immunopathology.
[679] J. Dayer,et al. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. , 1992, The Journal of clinical investigation.
[680] M. Meltzer,et al. Interactions between HIV‐infected monocytes and the extracellular matrix: HIV‐infected monocytes secrete neutral metalloproteases that degrade basement membrane protein matrices , 1992, Journal of leukocyte biology.
[681] Y. Sasaguri,et al. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. , 1992, The Biochemical journal.
[682] G. Opdenakker,et al. Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. , 1992, Cytokine.
[683] C. Azuma,et al. Malignant cell‐specific gelatinase activity in human endometrial carcinoma , 1992, Cancer.
[684] C. Hack,et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators , 1992, Infection and immunity.
[685] M. Stearns,et al. Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. , 1992, Cancer research.
[686] N. Koshikawa,et al. Activation of TIMP-2/progelatinase A complex by stromelysin. , 1992, Biochemical and biophysical research communications.
[687] Y. Kato,et al. Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. , 1992, The Journal of biological chemistry.
[688] G. N. Smith,et al. Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. , 1992, The Journal of rheumatology.
[689] A. Strongin,et al. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. , 1992, The Journal of biological chemistry.
[690] M. Hendrix,et al. Role of the alpha v beta 3 integrin in human melanoma cell invasion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[691] T. Hurskainen,et al. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. , 1992, Cancer research.
[692] J. Enghild,et al. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. , 1992, The Journal of biological chemistry.
[693] H. Tschesche,et al. Mercurial activation of human PMN leucocyte type IV procollagenase (gelatinase) , 1992, FEBS letters.
[694] K. Iwata,et al. Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum , 1992, FEBS letters.
[695] J. Delaissé,et al. Degradation of collagen in the bone‐resorbing compartment underlying the osteoclast involves both cysteine‐proteinases and matrix metalloproteinases , 1992, Journal of cellular physiology.
[696] R. Colman,et al. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. , 1992, The Journal of laboratory and clinical medicine.
[697] Z. Werb,et al. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. , 1992, Development.
[698] G Murphy,et al. A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.
[699] W. Stetler-Stevenson,et al. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. , 1992, The Journal of biological chemistry.
[700] U. Thorgeirsson,et al. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. , 1992, Invasion & metastasis.
[701] H. Sato,et al. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. , 1992, Oncogene.
[702] T. Hurskainen,et al. 70 K type IV collagenase (gelatinase). , 1992, Matrix (Stuttgart, Germany). Supplement.
[703] G. Opdenakker,et al. Chemotactic factors, passive invasion and metastasis of cancer cells. , 1992, Immunology today.
[704] W. Stetler-Stevenson,et al. Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. , 1991, Cancer research.
[705] M. Kuwano,et al. The response to epidermal growth factor of human maxillary tumor cells in terms of tumor growth, invasion and expression of proteinase inhibitors , 1991, International journal of cancer.
[706] E. Amento,et al. Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. , 1991, The Journal of clinical investigation.
[707] M. Matsubara,et al. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. , 1991, Developmental biology.
[708] A. Eisen,et al. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. , 1991, The Journal of investigative dermatology.
[709] L. Chow,et al. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. , 1991, The Journal of biological chemistry.
[710] W. Stetler-Stevenson,et al. Soluble laminin and arginine-glycine-aspartic acid containing peptides differentially regulate type IV collagenase messenger RNA, activation, and localization in testicular cell culture. , 1991, Biology of reproduction.
[711] R. Williamson,et al. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. , 1991, Biochemistry.
[712] V. Lefebvre,et al. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha. , 1991, Biochimica et biophysica acta.
[713] G. Opdenakker,et al. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. , 1991, Lymphokine and cytokine research.
[714] J. Wrana,et al. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. , 1991, The Journal of biological chemistry.
[715] E. Howard,et al. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. , 1991, The Journal of biological chemistry.
[716] H. Birkedal‐Hansen,et al. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. , 1991, The Journal of biological chemistry.
[717] G. Opdenakker,et al. Natural human monocyte gelatinase and its inhibitor , 1991, FEBS letters.
[718] G. Opdenakker,et al. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. , 1991, European journal of biochemistry.
[719] L. Moldawer,et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. , 1991, Journal of immunology.
[720] J. Auwerx,et al. The cytokine-protease connection: identification of a 96-kD THP-1 gelatinase and regulation by interleukin-1 and cytokine inducers. , 1991, Cytokine.
[721] S. Shapiro,et al. Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.
[722] R. Fridman,et al. Transforming growth factor-β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease , 1991 .
[723] S. Shapiro,et al. Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. , 1991, Journal of immunology.
[724] Z. Werb,et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts , 1991, The Journal of cell biology.
[725] F. Blasi,et al. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. , 1991, The Journal of biological chemistry.
[726] S. Maśliński,et al. Activation of the latent human neutrophil gelatinase by urea. , 1991, Acta biochimica Polonica.
[727] L. Liotta,et al. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. , 1991, Cancer research.
[728] U. Thorgeirsson,et al. Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. , 1990, The Journal of biological chemistry.
[729] L. Chow,et al. Structure and expression of type IV collagenase genes. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[730] C. Overall,et al. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. , 1990, The Journal of biological chemistry.
[731] S. Frisch,et al. Positive and negative transcriptional elements of the human type IV collagenase gene , 1990, Molecular and cellular biology.
[732] A Yasui,et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. , 1990, European journal of biochemistry.
[733] K. Suzuki,et al. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). , 1990, Biochemistry.
[734] A. Eisen,et al. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. , 1990, The Journal of clinical investigation.
[735] S. Shapiro,et al. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. , 1990, The Journal of clinical investigation.
[736] U. Moll,et al. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. , 1990, Cancer research.
[737] L. Liotta,et al. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. , 1990, Cancer research.
[738] G. Opdenakker,et al. Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate. , 1990, Biochimica et biophysica acta.
[739] Y. Okada,et al. Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. , 1990, Biochemical and biophysical research communications.
[740] J. P. Thompson,et al. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. , 1990, The Journal of biological chemistry.
[741] L. Chow,et al. Structure of the human type IV collagenase gene. , 1990, The Journal of biological chemistry.
[742] B. Wasylyk,et al. The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites. , 1990, The EMBO journal.
[743] R. Muschel,et al. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. , 1990, Cancer research.
[744] H. Birkedal‐Hansen,et al. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[745] K. Suzuki,et al. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. , 1990, Biochemistry.
[746] Andre Scedrov,et al. Functional polymorphism , 1990 .
[747] L. Wahl,et al. Inhibition of phospholipase activity in human monocytes by IFN-gamma blocks endogenous prostaglandin E2-dependent collagenase production. , 1990, Journal of immunology.
[748] L. Matrisian,et al. TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence , 1990, Cell.
[749] J. McKerrow,et al. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. , 1990, Cancer research.
[750] H. Tschesche,et al. Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms. , 1990, European journal of biochemistry.
[751] R. Eddy,et al. Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16. , 1990, Genomics.
[752] H. M. Lee,et al. The effect of phenytoin on collagenase and gelatinase activities in UMR 106-01 rat osteoblastic osteosarcoma cells. , 1990, Matrix.
[753] H. Kleinman,et al. Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[754] B. Martin,et al. Differentiation of HL-60 Promyelocytic Leukemia Cells: A Member of the Collagenase Family of Enzymes , 1990 .
[755] E. Appella,et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.
[756] S. Frisch,et al. Secreted Proteases , 1990 .
[757] J. Lacal,et al. Differential effects of phorbol ester on the in vitro invasiveness of malignant and non‐malignant human fibroblast cells , 1990, Journal of cellular physiology.
[758] D. Schurman,et al. Septic arthritis. Staphylococcal induction of chondrocyte proteolytic activity. , 1990, Arthritis and rheumatism.
[759] S. Frisch,et al. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. , 1990, Oncogene.
[760] K. Suzuki,et al. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. , 1989, The Journal of clinical investigation.
[761] A. Eisen,et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.
[762] G. Zhang,et al. Adhesive and degradative properties of human placental cytotrophoblast cells in vitro , 1989, The Journal of cell biology.
[763] Z. Werb,et al. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression , 1989, The Journal of cell biology.
[764] R. Nicholson,et al. Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases. , 1989, Biochemistry.
[765] Y. Okada,et al. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin G , 1989, FEBS letters.
[766] H. Nakagawa,et al. Activation by cathepsin G of latent gelatinase secreted from rat polymorphonuclear leukocytes. , 1989, Chemical & pharmaceutical bulletin.
[767] M. Hendrix,et al. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. , 1989, Cancer research.
[768] J. Wrana,et al. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. , 1989, Connective tissue research.
[769] L. Liotta,et al. Purification of a gelatin-degrading type IV collagenase secreted by ras oncogene-transformed fibroblasts. , 1988, Journal of the National Cancer Institute.
[770] D. Gomez,et al. Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. , 1988, Biochemical and biophysical research communications.
[771] J. Seltzer,et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.
[772] R. Rees,et al. Modulation of type IV collagenase and plasminogen activator in a hamster fibrosarcoma by basement membrane components and lung fibroblasts. , 1988, British Journal of Cancer.
[773] J. van Beeumen,et al. A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity , 1988, The Journal of experimental medicine.
[774] R. Dwek,et al. Glycobiology , 2018, Biochimie.
[775] A. Kang,et al. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. , 1987, The Journal of clinical investigation.
[776] M. Karin,et al. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP , 1987, Cell.
[777] L. Lund,et al. Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells , 1987, Molecular and cellular biology.
[778] L. Ala‐Kokko,et al. Dexamethasone modulates the metabolism of type IV collagen and fibronectin in human basement-membrane-forming fibrosarcoma (HT-1080) cells. , 1987, The Biochemical journal.
[779] M. Karin,et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.
[780] L. Liotta,et al. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. , 1987, Cancer research.
[781] H. Nakagawa,et al. Partial purification and characterization of exudate gelatinase in the acute phase of carrageenin-induced inflammation in rats. , 1986, Journal of biochemistry.
[782] S. Weiss,et al. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[783] L. Liotta,et al. Laminin increases the release of type IV collagenase from malignant cells. , 1986, The Journal of biological chemistry.
[784] J. Uitto,et al. Glucocorticoid action on connective tissue: from molecular mechanisms to clinical practice. , 1986, Medical biology.
[785] P. Stephens,et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity , 1985, Nature.
[786] Y. Nishizuka. The role of protein kinase C in cell surface signal transduction and tumour promotion , 1984, Nature.
[787] M. Jochum,et al. Proteinases and their inhibitors in septicemia - basic concepts and clinical implications. , 1984, Advances in experimental medicine and biology.
[788] J. Uitto,et al. Proteinases in Human Polymorphonuclear Leukocytes , 1983 .
[789] P. Roche,et al. Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein. , 1983, Biochimica et biophysica acta.
[790] J. Uitto,et al. Proteinases in human polymorphonuclear leukocytes. Purification and characterization of an enzyme which cleaves denatured collagen and a synthetic peptide with a Gly-Ile sequence. , 1983, European journal of biochemistry.
[791] C. Brosnan,et al. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis , 1980, Nature.
[792] E. Dowdle,et al. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.
[793] A. Granelli‐Piperno,et al. A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.
[794] G. Vaes,et al. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. , 1977, The Biochemical journal.
[795] Z. Werb,et al. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. , 1977, The New England journal of medicine.
[796] W. Mcdonald,et al. Leucocyte proteinase activity and acute multiple sclerosis , 1975, Journal of Neurological Sciences.
[797] S. Krane,et al. An endopeptidase from rheumatoid synovial tissue culture. , 1972, Biochimica et biophysica acta.
[798] W. Wooster,et al. Crystal structure of , 2005 .